Conferences Silence Therapeutics is attending in 2026

LinkedIn silence-therapeutics.com

Silence Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026: TIDES Europe 2026 (on the program) and ASH 2026 (exhibiting). Silence Therapeutics develops RNA interference therapeutics for genetically defined diseases. As of Sep 29, 2026.

ConferenceDetailsInvolvementTnuki guide
TIDES Europe 2026: Oligonucleotide & Peptide TherapeuticsOligonucleotide & peptide drug developersOfficial site
Amsterdam, Netherlands ~900 attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 2 talks
Attending
  • VP, Group Leader Chemistry
Attendee mix: Mostly industry; oligonucleotide and peptide R&D scientists, CMC and manufacturing specialists, regulatory and BD
Open the guide Search and filter attendees
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site
New Orleans, LA ~30k attendees ExhibitorAs published by American Society of Hematology
Booth 454
Attendee mix: Mostly clinical; hematologists, KOLs, hematologic-oncology researchers, medical affairs and cell-therapy biopharma teams
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 29 of the 90 conferences on our calendar, so this page shows Silence Therapeutics’s involvement at those 29 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Silence Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →